Summary

for people ages 12 years and up (full criteria)
at Sacramento, California
study started
estimated completion
Michael Schivo, MD, MAS

Description

Summary

Respiratory virus infections cause a majority of asthma exacerbations in the fall to spring months. Current diagnostic platforms for respiratory viruses have limitations including cost, availability, and invasiveness. The use of noninvasive breath collection to analyze breath metabolites may be used to differentiate virus-infected asthmatics from other causes of acute asthma exacerbations.

Official Title

Using Breath Metabolites to Determine Specific Virus Infection in Asthmatic Patients

Keywords

Upper Respiratory Tract Infections, Asthma, Exhaled Breath Infection Communicable Diseases Virus Diseases Respiratory Tract Infections Exhaled breath condensate collection Rhinovirus-infected asthmatics Influenza A-infected asthmatics

Eligibility

You can join if…

Open to people ages 12 years and up

  • Asthma, Age ≥12, Symptoms/signs of an early asthma exacerbation, Ability to provide exhaled breath condensate (EBC) x15 min, Body mass index (BMI) ≥18

You CAN'T join if...

  • Chronic lung diseases other than asthma (e.g., chronic obstructive pulmonary disease [COPD], lung cancer, fibrotic lung disease, etc.), Smoking in the past 7 days, Eating or non-clear liquids <4 hrs prior to EBC collection, Pregnancy

Location

  • University of California Davis Medical Ceneter accepting new patients
    Sacramento California 96817 United States

Lead Scientist

  • Michael Schivo, MD, MAS
    Associate Professor, Pulmonary, Critical Care, and Sleep Medicine. Authored (or co-authored) 25 research publications

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, Davis
Links
Sign up for this study
ID
NCT03089970
Study Type
Observational
Last Updated